Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sacubitril/valsartan vs azilsartan for left ventricular remodeling in hypertension with elevated ANGPTL7
ChiCTR2300073598Phase 4Not yet recruiting
- Sponsor
- First People's Hospital of Lianyungang City
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of sacubitril + valsartan and azilsartan in hypertension (HTN) (2 arms), sponsored by First People's Hospital of Lianyungang City. Primary endpoints: Systolic blood pressure and Diastolic blood pressure. Planned start Oct 2022; status: not yet recruiting.
02
Drugs
sacubitril + valsartanazilsartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on ChiCTR2300073598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300073598.